European Union Regulator Says Benefits Outweigh Risks Of Johnson & Johnson Vaccine wyomingpublicmedia.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wyomingpublicmedia.org Daily Mail and Mail on Sunday newspapers.
2021-04-20 22:06:06 GMT2021-04-21 06:06:06(Beijing Time) Xinhua English
BRUSSELS, April 20 (Xinhua) The European Medicines Agency (EMA) said on Tuesday it had found a possible link between the Johnson & Johnson COVID-19 vaccine and cases of blood clots, but insisted that its benefits outweigh the risks. A careful review of the cases and other available evidence has led us to affirm that these blood clotting disorders are very rare side effects of the vaccine, said Sabine Straus, president of the EMA s safety committee, at a press conference.
On April 13, the medicines watchdog of the European Union (EU) was informed of eight serious cases of unusual blood clots associated with low levels of blood platelets, one of which had a fatal outcome. All the cases occurred in the United States, where over seven million people received the Johnson & Johnson vaccine.
EU: J&J vaccine linked to rare blood clots, but benefits outweigh risks winknews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from winknews.com Daily Mail and Mail on Sunday newspapers.
EU regulator backs Johnson & Johnson’s COVID-19 vaccine despite finding possible link to rare blood clots Pushkala Aripaka, Anthony Deutsch and John Miller Reuters Bookmark Please log in to listen to this story. Also available in French and Mandarin. Log In Create Free Account
Getting audio file . This translation has been automatically generated and has not been verified for accuracy. Full Disclaimer
SHANNON STAPLETON/Reuters
Europe’s drug regulator has found a possible link between Johnson & Johnson’s COVID-19 vaccine and rare blood clotting issues in adults who received doses in the United States, but backed its overall benefits against any risks.
Johnson & Johnson to cooperate in study of rare clots linked to COVID-19 vaccine, German scientist says Toggle share menu
Advertisement
Advertisement World
Johnson & Johnson to cooperate in study of rare clots linked to COVID-19 vaccine, German scientist says
A vial and sryinge are seen in front of a displayed Johnson&Johnson logo in this illustration taken Jan 11, 2021. (Photo: REUTERS/Dado Ruvic)
21 Apr 2021 04:49AM Share this content
Bookmark
ZURICH: A German scientist studying extremely rare blood clots linked to AstraZeneca s COVID-19 vaccine said on Tuesday (Apr 20) Johnson & Johnson has agreed to work with him on the research after similar serious side effects emerged in recipients of its shot.